Drugs / Haemate HS
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00618293 Comparator | Jan 2008 → Jul 2010 | — | Heinrich-Heine University, Duesseldorf | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Haemate HS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00618293 ↗ |
| Modality | Protein / enzyme biologic | “Von Willebrand factor concentrate F VIII (Haemate)” NCT00618293 ↗ |
| Route | Intravenous | “intravenous infusion of Haemate (dosage dependent on body weight)” NCT00618293 ↗ |